微创颅内血肿清除术治疗高血压性基底节区脑出血的临床疗效观察

发布时间：2018-06-05 12:02

本文选题：微创颅内血肿清除术 + 高血压性基底节区脑出血　；参考：《当代医学》2018年07期

【摘要】：目的观察分析微创颅内血肿清除术治疗高血压性基底节区脑出血的临床效果。方法从本院自2015年4月~2016年3月收治的高血压性基底节区脑出血患者资料中选取120例并对其进行回顾性分析。按照治疗方式的差异性将其均分为观察组和对照组,观察组行微创颅内血肿清除术,对照组行常规治疗,对比患者接受治疗前后的治疗有效率、巴氏指数、神经功能缺损评分、血清S-100蛋白浓度、NSE浓度以及住院时间。结果两组患者在神经功能缺损评分、血清S-100蛋白浓度、NSE浓度和巴氏指数等方面比较:治疗前以上因素无统计学意义。治疗后差异有统计学意义(P0.05)。结论微创颅内血肿清除术对高血压性基底节区脑出血的治疗具有显著效果,值得临床推广。
[Abstract]:Objective to observe the clinical effect of minimally invasive intracerebral hematoma removal for hypertensive basal ganglia hemorrhage. Methods from April 2015 to March 2016, 120 patients with hypertensive basal ganglia hemorrhage were selected and analyzed retrospectively. According to the difference of treatment methods, the patients were divided into observation group and control group. The observation group received minimally invasive intracerebral hematoma removal, and the control group received routine treatment. The effective rate, pasteurization index and neurological impairment score of the patients before and after treatment were compared. Serum S-100 protein concentration, NSE concentration and hospitalization time. Results the neurological impairment score, serum S-100 protein concentration, NSE concentration and pasteurian index were compared between the two groups: there was no significant difference between the above factors before treatment. The difference after treatment was statistically significant (P 0.05). Conclusion minimally invasive removal of intracranial hematoma is effective in the treatment of hypertensive basal ganglia hemorrhage.
【作者单位】：中国人民解放军第八十八医院神经外科;
【分类号】：R651.1

【相似文献】